References
- A. Gadducci, S. Carinelli, G. Aletti, Neuroendrocrine tumors of the
uterine cervix: a therapeutic challenge for gynecologic oncologists,
Gynecol. Oncol. 144 (3) (2017) 637–646.
- Viswanathan AN, Deavers MT, Jhingran A et al. Small cell
neuroendocrine carcinoma of the cervix: outcome and patterns of
recurrence. Gynecol Oncol 2004; 93: 27–33.
- Crowder S, Tuller E. Small cell carcinoma of the female genital tract.
Semin Oncol 2007; 34: 57–63.
- Chung HH, Jang MJ, Jung KW et al. Cervical cancer incidence and
survival in Korea: 1993–2002. Int J Gynecol Cancer 2006; 16:
1833–1838.
- Kim YM, Jung MH, Kim DY, et al. Small cell carcinoma of the uterine
cervix: clinicopathologic study of 20 cases in a single center. Eur J
Gynaecol Oncol. 2009;30:539Y542.
- Chen J, Macdonald OK, Gaffney DK. Incidence, mortality, and prognostic
factors of small cell carcinoma of the cervix. Obstet Gynecol.
2008;111:1394Y1402.
- S. Kuji, Y. Hirashima, H. Nakayama, S. Nishio, T. Otsuki, Y.
Nagamitsu, et al., Diagnosis, clinicopathologic features, treatment,
and prognosis of small cell carcinoma of the uterine cervix; Kansai
Clinical Oncology Group/Intergroup study in Japan, Gynecol. Oncol. 129
(3) (2013) 522–527.
- Zivanovic O, Leitao MM Jr., Park KJ, et al. Small cell neuroendocrine
carcinoma of the cervix: Analysis of outcome, recurrence pattern and
the impact of platinum-based combination chemotherapy. Gynecol Oncol.
2009;112:590Y593.
- Wang KL, Chang TC, Jung SM, et al. Primary treatment and prognostic
factors of small cell neuroendocrine carcinoma of the uterine cervix:
a Taiwanese Gynecologic Oncology Group study. Eur J Cancer.
2012;48:1484Y1494.
- Sundstrom S, Bremnes RM, Kaasa S, et al. Cisplatin and etoposide
regimen is superior to cyclophosphamide, epirubicin, and vincristine
regimen in small-cell lung cancer: results from a randomized phase III
trial with 5 years’ follow-up. J Clin Oncol. 2002;20:4665Y72.
- Liao LM, Zhang X, Ren YF, et al. Chromogranin A (CgA) as poor
prognostic factor in patients with small cell carcinoma of the cervix:
results of a retrospective study of 293 patients. PloS One.
2012;7:e33674.
- Kuji S, Hirashima Y, Nakayama H, et al. Diagnosis, clinicopathologic
features, treatment, and prognosis of small cell carcinoma of the
uterine cervix; Kansai Clinical Oncology Group/Intergroup study in
Japan. Gynecol Oncol. 2013;129:522Y527.
- Naidoo J, Teo MY, Deady S, et al. Should patients with extrapulmonary
small-cell carcinoma receive prophylactic cranial irradiation? J
Thorac Oncol. 2013;8:1215Y1221.
- Satoh T, Takei Y, Treilleux I, et al. Gynecologic Cancer InterGroup
(GCIG) Consensus Review for Small Cell Carcinoma of the Cervix[J].
International Journal of Gynecological Cancer Official Journal of the
International Gynecological Cancer Society, 2014, 24(9):S102.
- J.M. Lee, K.B. Lee, J.H. Nam, et al. Prognostic factors in FIGO stage
IB–IIA small cell neuroendocrine carcinoma of the uterine cervix
treated surgically: results of a multi-center retrospective Korean
study. Annals of Oncology 19: 321–326, 2008.
- N. Bhatla, D. Aoki, D.N. Sharma, e Zivanovic t al., Cancer of the
cervix uteri, Int. J. Gynecol. Obstet. 143 (2018) 22–36.
- Ambros RA, Park JS, Shah KV, Kurman RJ. Evaluation of histologic,
morphometric, and immunohistochemical criteria in the differential
diagnosis of small cell carcinomas of the cervix with particular
reference to human papillomavirus types 16 and 18. Mod Pathol
1991;4:586–93.
- Stoler MH, Mills SE, Gersell DJ, Walker AN. Small-cell neuroendocrine
carcinoma of the cervix. A human papillomavirus type 18-associated
cancer. Am J Surg Pathol 1991;15:28–32.
- Ginger J. Gardner, Diane Reidy-Lagunes, Paola A. Gehrig.
Neuroendocrine tumors of the gynecologic tract: A Society of
Gynecologic Oncology (SGO) clinical document. Gynecologic Oncology 122
(2011) 190–198.
- J.G. Cohen, D.S. Kapp, J.Y. Shin, R. Urban, A.E. Sherman, L.M. Chen,
et al., Small cell carcinoma of the cervix: treatment and survival
outcomes of 188 patients, Am. J. Obstet. Gynecol. 203 (4) (2010) 347
e1–6.
- NCCN clinical practice guidelines in Oncology:Small Cell Lung Cancer.
Version 1, 2021.
https://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
Accessed 2 October 2020. In.
- Loehrer PJ Sr, Einhorn LH, Greco FA. Cisplatin plus etoposide in small
cell lung cancer. Semin Oncol. 1988 Jun;15(3 Suppl 3):2-8.
- Roth, B. J., Johnson, D. H., Einhorn, et al. Randomized study of
cyclophosphamide, doxorubicin, and vincristine versus etoposide and
cisplatin versus alternation of these two regimens in extensive
smallcell lung cancer: A phase III trial of the Southeastern Cancer
Study Group. Journal of Clinical Oncology 10(2), 282–291.
- Noda, K., Nishiwaki, Y., Kawahara, M., et al. Irinotecan plus
cisplatin compared with etoposide plus cisplatin for extensive
small-cell lung cancer. The New England Journal of Medicine 346(2),
85–91.
- C-H Kuo, C-C Hsieh, M-L Chan, et al. Small cell carcinoma of the
esophagus: a report of 16 cases from a single institution and
literature review. Ann Thorac Surg. 2011;91(2):373-8.
- J E Lee, S H Hong, H I Jung, et al. Small-cell neuroendocrine
carcinoma of the ileum: case report and literature review. BMC Surg.
2019;19(1):135.
- N Shahab. Extrapulmonary small cell carcinoma of the bladder. Semin
Oncol. 2007;34(1):15-21.
- X Pei, L B Xiang, S Ye, et al. Cycles of cisplatin and etoposide
affect treatment outcomes in patients with FIGO stage I-II small cell
neuroendocrine carcinoma of the cervix. Gynecologic Oncology.
147;589-596.
- Bermudez A, Vighi S, Garcia A, Sardi J. Neuroendocrine cervical
carcinoma: a diagnostic and therapeutic challenge. Gynecol Oncol
2001;82:32–9.
- Chang TC, Lai CH, Tseng CJ, Hsueh S, Huang KG, Chou HH. Prognostic
factors in surgically treated small cell cervical carcinoma followed
by adjuvant chemotherapy. Cancer 1998;83:712–8.
- Chang TC, Hsueh S, Lai CH, Tseng CJ, Lee KF, Huang KG, et al. Phase II
trial of neoadjuvant chemotherapy in early-stage small cell cervical
cancer. Anticancer Drugs 1999;10:641–6.
Table 1. General characteristics.